Although the function of anti-CNTN1 autoantibodies in the conjunction of CIDP and MN is unknown however, in patients with aggressive CIDP who also have positive CNTN1 autoantibodies, the presence of CNTN1 antibodies may be a unique biomarker and prompt further evaluation [8]. The gene discussed is CNTN1; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.